ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

34,128Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 2888

$2.12M Total Retail Price of All Prescriptions

Rank: 21 out of 2888

834 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 834 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

31% of this provider’s 834 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 28,092 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
AMLODIPINE BESYLATE 1,105 971 1 5
LISINOPRIL 1,095 907 2 3
FUROSEMIDE 1,055 903 3 6
LEVOTHYROXINE SODIUM 983 856 4 1
METOPROLOL TARTRATE 972 799 5 10
HYDROCODONE-ACETAMINOPHEN 957 741 S3 6 4
SIMVASTATIN 885 682 7 2
DONEPEZIL HCL 771 694 8 26
OMEPRAZOLE 700 582 9 7
QUETIAPINE FUMARATE 627 512 10 66
WARFARIN SODIUM 552 441 11 22
TRAMADOL HCL 531 473 12 16
POTASSIUM CHLORIDE 526 424 13 14
LEVETIRACETAM 445 352 14 103
HYDROCHLOROTHIAZIDE 445 406 14 15
CYMBALTA 440 331 16 44
NAMENDA 424 395 17 34
LACTULOSE 417 331 18 111
RISPERIDONE 400 349 19 72
SERTRALINE HCL 382 284 20 27
GABAPENTIN 382 291 20 13
METFORMIN HCL 381 258 22 8
LANTUS 364 234 23 45
CARVEDILOL 357 291 24 21
TRAZODONE HCL 345 253 25 43
CLONIDINE HCL 344 262 26 39
MIRTAZAPINE 342 312 27 54
CITALOPRAM HBR 323 244 28 24
RANITIDINE HCL 285 261 29 56
ALBUTEROL SULFATE 280 260 30 134
SANTYL 279 247 31 210
DIVALPROEX SODIUM 260 219 32 100
FAMOTIDINE 250 213 33 75
HYDRALAZINE HCL 245 192 34 59
METOPROLOL SUCCINATE 244 220 35 11
TAMSULOSIN HCL 234 184 36 29
DIGOXIN 228 204 37 55
SEROQUEL 227 188 38 143
PANTOPRAZOLE SODIUM 226 199 39 33
ATORVASTATIN CALCIUM 224 197 40 9
CLOPIDOGREL 217 193 41 30
BENZTROPINE MESYLATE 204 184 R 42 191
ESCITALOPRAM OXALATE 198 191 43 62
MEGESTROL ACETATE 197 178 R 44 140
ATENOLOL 196 196 45 25
PREDNISONE 189 173 46 42
LATANOPROST 179 170 47 197
PHENYTOIN SODIUM EXTENDED 178 106 48 128
AMIODARONE HCL 174 159 49 167
PLAVIX 171 160 50 40
GLIPIZIDE 168 118 51 50
FENTANYL 167 114 S2 52 126
DIOVAN 165 142 53 35
CEFTRIAXONE 164 139 54 281
CARBIDOPA-LEVODOPA 160 156 55 113
RAMIPRIL 158 147 56 73
LANTUS SOLOSTAR 153 119 57 92
LIDODERM 144 121 58 105
METOCLOPRAMIDE HCL 143 103 59 116
NOVOLIN R 141 112 60 109
NYSTATIN 140 110 61 178
SULFAMETHOXAZOLE-TRIMETHOPRIM 139 106 62 88
DIVALPROEX SODIUM ER 139 80 62 185
ZOLPIDEM TARTRATE 135 56 64 17
LYRICA 135 116 64 69
ADVAIR DISKUS 133 123 66 60
IPRATROPIUM BROMIDE 133 127 66 188
LOSARTAN POTASSIUM 132 113 68 18
NIFEDIPINE ER 130 105 69 76
POLYETHYLENE GLYCOL 3350 128 97 70 93
GLUCAGEN 125 80 71 288
TRANSDERM-SCOP 117 96 10 72 388
BYSTOLIC 115 89 73 99
VANCOMYCIN HCL 114 104 74 391
SPIRIVA 112 99 75 79
METHADONE HCL 112 98 S2 75 216
CELEBREX 112 100 75 89
BACLOFEN 109 43 78 121
LEVOFLOXACIN 107 84 79 57
OLANZAPINE 106 78 80 137
SPIRONOLACTONE 101 98 81 70
LABETALOL HCL 98 78 82 180
ABILIFY 98 65 82 172
PROMETHAZINE HCL 97 67 R 84 96
IPRATROPIUM-ALBUTEROL 96 86 85 150
CLONIDINE 96 92 85 247
FLUTICASONE PROPIONATE 95 83 87 32
FINASTERIDE 95 94 87 102
LIDOCAINE HCL 94 83 89 297
NOVOLOG 93 72 90 114
TRAVATAN Z 92 71 91 239
MELOXICAM 90 78 92 31
ALLOPURINOL 89 66 93 37
KLOR-CON M20 88 63 94 90
RENVELA 88 49 94 279
ISOSORBIDE MONONITRATE ER 88 65 94 51
AMOX TR-POTASSIUM CLAVULANATE 87 69 97 112
JANUVIA 84 66 98 48
SPS 83 64 99 499
ALENDRONATE SODIUM 82 82 100 23
MUPIROCIN 81 67 101 184
NITROGLYCERIN PATCH 80 78 102 183
NOVOLIN N 80 64 102 255
LEVEMIR 80 53 102 135
EXELON 77 71 105 106
LEXAPRO 75 74 106 198
TERAZOSIN HCL 75 62 106 152
GLIPIZIDE ER 74 72 108 107
NOVOLIN 70-30 73 53 109 144
PRAVASTATIN SODIUM 65 63 110 12
SINGULAIR 64 55 111 85
CRESTOR 64 53 111 20
BUSPIRONE HCL 64 47 111 148
CIPROFLOXACIN HCL 63 55 114 47
DETROL LA 63 51 114 192
VENLAFAXINE HCL ER 61 45 116 120
HUMALOG 61 49 116 166
VALPROIC ACID 61 42 116 278
TIMOLOL MALEATE 61 60 116 348
FLUCONAZOLE 60 51 120 199
FLUOXETINE HCL 59 43 121 83
FENOFIBRATE 59 46 121 65
BRIMONIDINE TARTRATE 58 46 123 338
ENOXAPARIN SODIUM 58 51 123 307
PAROXETINE HCL 57 48 125 84
TRICOR 56 49 126 91
NEXIUM 56 53 126 19
DILANTIN 54 54 128 326
SODIUM CHLORIDE 53 47 129 371
HUMULIN R 53 47 129 233
ENULOSE 52 49 131 586
AZITHROMYCIN 51 37 132 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 31, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.